Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05853393
Other study ID # STUDY00020663
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 20, 2023
Est. completion date June 2024

Study information

Verified date May 2023
Source Penn State University
Contact Emily E Hohman, PhD
Phone 8148655245
Email eeh12@psu.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this study is to learn about how children's sleep is related to their eating behaviors the next day, and to learn about factors that relate to eating behaviors and sleep health that are specific to preadolescent children living in rural communities.


Description:

The aims of this study are to a) describe the prevalence and characteristics of eating in the absence of hunger (EAH) in rural preadolescent children using a novel methodology, ecological momentary assessment (EMA); b) to examine the within-person temporal relationship between daily changes in sleep health (i.e., duration and quality) and EAH; and c) examine associations between family, child, and environmental characteristics, sleep, and eating behaviors in rural preadolescent children. Parent-child dyads will participate in the study via remote data collection methods including Zoom interviews, online surveys, EMA survey completed by smartphone, and actigraphy.


Recruitment information / eligibility

Status Recruiting
Enrollment 128
Est. completion date June 2024
Est. primary completion date June 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 8 Years and older
Eligibility Child Inclusion Criteria: 1. Age 8 to 12 years 2. Primary residence is in a rural ZIP code in the United States, as defined by Health Resources & Services Administration 3. BMI for age = 85th percentile OR BMI = 15th percentile plus at least one biological parent with BMI = 25 kg/m2 4. Able to read and answer questions in English Parent Inclusion criteria: 1. Parent or caregiver of an eligible child 2. Age 18 years or older 3. Able to read and answer questions in English Exclusion Criteria: 1. Any medical condition that significantly impacts eating, sleep, growth, or ability to operate the mEMA smartphone platform (e.g., eating disorder, Type I diabetes, blindness) (Child participants only) 2. Unable to connect to a Zoom session via internet or cell-phone data from home 3. Unable to receive and sign for package with study supplies

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Pennyslvania State University University Park Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Penn State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Occurrence of eating in the absence of hunger (EAH) episodes Eating events where pre-meal hunger is less than 35 on a 100 point visual analogue scale, as reported on smartphone surveys that are completed multiple times a day over a 2 week period. Multiple measurements per day for 2 weeks starting at enrollment through 2 weeks
Secondary Visual analogue scale rating of hunger Collected via EMA Multiple measurements per day for 2 weeks
Secondary Visual analogue scale rating of fullness Collected via EMA Multiple measurements per day for 2 weeks
Secondary Visual analogue scale rating of desire to eat Collected via EMA Multiple measurements per day for 2 weeks
Secondary Child appetitive traits Measured by parent report questionnaire (Child Eating Behavior Questionnaire) At enrollment
Secondary Child mindful eating Measured by child self report questionnaire (Mindful Eating Questionnaire) At enrollment
Secondary Child eating motivations Measured by child self report questionnaire (Palatable Eating Motives Questionnaire) At enrollment
Secondary Child restrained and disinhibited eating Measured by child self report questionnaire (Dutch Eating Behavior Questionnaire) At enrollment
Secondary Sleep duration Measured by actigraphy Daily over 2 weeks
Secondary Sleep maintenance efficiency Measured by actigraphy Daily over 2 weeks
Secondary Body mass index z-score Calculated from measured height and weight At enrollment
See also
  Status Clinical Trial Phase
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Recruiting NCT06079853 - Nurse Suicide: Physiologic Sleep Health Promotion Trial N/A
Completed NCT05017974 - Research on Improving Sleep During Pregnancy N/A
Recruiting NCT05206747 - Ottawa Sunglasses at Night for Mania Study N/A
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT04513743 - Ultra Long-Term Sleep Monitoring Using UNEEG™ Medical 24/7 EEG™ SubQ N/A
Completed NCT03251274 - Bath Machine on Sleep Quality in Nursing Home N/A
Completed NCT04102345 - Lavender vs Zolpidem Sleep Quality During Diagnostic PSG Early Phase 1
Completed NCT03725943 - Comparison of Dreem to Clinical PSG for Sleep Monitoring in Healthy Adults N/A
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT04562181 - Consistency Evaluation of the qCON, qNOX Indices and Bispectral Index N/A
Completed NCT05576844 - Ai Youmian (Love Better Sleep) for People Living With HIV N/A
Completed NCT05102565 - A Dyadic Telehealth Program for Alzheimer's Patients/Caregivers N/A
Completed NCT04688099 - Synovial Fluid Sleep Study
Recruiting NCT04171245 - Prescribing Laughter for Sleep and Wellbeing in UAE University Students N/A
Completed NCT03758768 - The Effects of a Blue Monochromatic Light Intervention on Evening-type Individuals' Sleep and Circadian Rhythms N/A
Completed NCT03163498 - Evaluation of Sleep Pattern and Mood Profile in Hypertensive Patients
Completed NCT04093271 - Investigating the Efficacy of Rest-ZZZ Formula in Healthy Participants With Difficulty Falling Asleep or Staying a Sleep Phase 1
Completed NCT03673397 - The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression N/A
Completed NCT04120363 - Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations Phase 4